Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Aldeyra Therapeutics (ALDX) Prices 2.2M Offering of Common Stock at $4.50/Share
-
Aldeyra Therapeutics, Inc. Prices Public Offering of Common Stock
-
Seabridge Gold to Acquire Snowstorm Project
-
Vernalis achieves a $3 million milestone payment from Corvus Pharmaceuticals Inc
-
Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants
-
Aldeyra Therapeutics (ALDX) Plans Offering of Common Stock
-
Aldeyra Therapeutics, Inc. Proposes Public Offering of Common Stock
-
Canaccord Genuity Downgrades ZELTIQ Aesthetics (ZLTQ) to Hold
-
Vermilion Energy Inc. Announces $0.215 CDN Cash Dividend for March 15, 2017 Payment Date
-
Namaste Applies to Trade on OTCQB
-
Corrections Corporation of America (CXW) PT Raised to $34 at Canaccord Genuity
-
NVIDIA (NVDA) PT Raised to $130 at Canaccord Genuity Following 4Q
-
Dividend 15 Split Corp. Completes Overnight Offering of $64,023,200
-
AltaGas Ltd. Announces Monthly Dividend
-
Canaccord Genuity Downgrades Intel (INTC) to Hold
-
Canaccord Genuity Announces Official Transition of Chief Financial Officer and Chief Risk Officer Roles
-
Canaccord Genuity Group Inc. Reports Third Quarter Fiscal 2017 Results
-
Twitter (TWTR) PT Lowered to $15 at Canaccord Genuity
-
Helius Medical Technologies Inc. Announces CAD$10.8 Million Public Offering of Class A Common Stock
-
Advisory Board Company (ABCO) PT Raised to $56 at Canaccord Genuity
-
Erin Energy Announces Debt Financing
-
Helius Medical Technologies, Inc. Announces Proposed Public Offering of Class A Common Stock
-
Galena Biopharma (GALE) Prices Offering at $1/Share, w/Warrants
-
Canaccord Genuity Downgrades SPS Commerce (SPSC) to Hold
-
Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
-
Galena Biopharma (GALE) to Offer Common Stock and Warrants
-
Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants
-
Just Energy Group Announces Closing of Public Offering and Private Placement of Series A Preferred Shares Raising Gross Proceeds of US$101 Million
-
Apple (AAPL) PT Raised to $154 at Canaccord Genuity
-
SpineGuard Extends the Utility of Its Dynamic Surgical Guidance (DSG ™) Technology Platform by Receiving US Patent for “Bone Quality Measurement” Application
-
SpineGuard Extends the Utility of Its Dynamic Surgical Guidance (DSG™) Technology Platform by Receiving US Patent for “Bone Quality Measurement” Application
-
Dalradian receives $7.2 million from warrant exercise
-
Reata Scheduled to Attend Upcoming Investor Conferences
-
Ithaca Energy Inc Announces Recommended Takeover by Delek
-
Robix Announces Option Grant, Shares for Debt Private Placement and Debt Settlement
-
LexaGene Announces Appointment of New President
-
Seres Therapeutics Announces Participation at Two Upcoming Investor Conferences
-
Atalaya Mining PLC: Astor Management AG litigation case update
-
Strongbridge Biopharma plc to Participate in the Canaccord Genuity Rare Disease and BioPharma One-on-One Day
-
Facebook (FB) PT Raised to $155 at Canaccord Genuity, "We Continue To Like The Stock"
-
Summit Therapeutics to Participate in February Investor Conferences
-
Aptose Biosciences to Present at Canaccord Genuity Rare Disease Biopharma 1x1 Day
-
Gemphire Therapeutics to Participate in the Canaccord Genuity Rare Disease and Biopharma 1 on 1 Day and the RBC Capital Markets Global Healthcare Conference
-
AMD (AMD) PT Raised to $14 at Canaccord Genuity
-
Apple (AAPL) PT Raised to $142 at Canaccord Genuity
-
Synergy Pharma (SGYP) Prices 20.3M Shares at $6.15
-
Synergy Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Abraxas Petroleum Corporation Announces Exercise and Closing of Over-Allotment Option
-
Synergy Pharma (SGYP) to Offer $125M in Common Stock
-
Synergy Pharmaceuticals Announces Proposed Public Offering of Common Stock

